Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

BACKGROUND: Variations in single nucleotide polymorphisms (SNPs) have been associated with enhanced drug efficacy and toxicity in cancer therapy. SNP variations in the ErbB2 gene have been identified that alter the protein sequence of the HER2-neu protein, but how these polymorphisms affect prognosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanton, Sasha E, Ward, Maureen M, Christos, Paul, Sanford, Rachel, Lam, Christina, Cobham, Marta V, Donovan, Diana, Scheff, Ronald J, Cigler, Tessa, Moore, Anne, Vahdat, Linda T, Lane, Maureen E, Chuang, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403678/
https://www.ncbi.nlm.nih.gov/pubmed/25885598
http://dx.doi.org/10.1186/s12885-015-1298-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403678/
https://www.ncbi.nlm.nih.gov/pubmed/25885598
http://dx.doi.org/10.1186/s12885-015-1298-6

Ejemplares similares